Authors:
El Yacoubi, M
Ledent, C
Parmentier, M
Ongini, E
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., In vivo labelling of the adenosine A(2A) receptor in mouse brain using theselective antagonist [H-3]SCH 58261, EUR J NEURO, 14(9), 2001, pp. 1567-1570
Authors:
Ongini, E
Monopoli, A
Impagnatiello, F
Fredduzzi, S
Schwarzschild, M
Chen, JF
Citation: E. Ongini et al., Dual actions of A(2A) adenosine receptor antagonists on motor dysfunction and neurodegenerative processes, DRUG DEV R, 52(1-2), 2001, pp. 379-386
Authors:
Chen, JF
Moratalla, R
Impagnatiello, F
Grandy, DK
Cuellar, B
Rubinstein, M
Beilstein, MA
Hackett, E
Fink, JS
Low, MJ
Ongini, E
Schwarzschild, MA
Citation: Jf. Chen et al., The role of the D2 dopamine receptor (D2R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D-2 receptor knockout mice, P NAS US, 98(4), 2001, pp. 1970-1975
Authors:
El Yacoubi, M
Ledent, C
Parmentier, M
Bertorelli, R
Ongini, E
Costentin, J
Vaugeois, JM
Citation: M. El Yacoubi et al., Adenosine A(2A) receptor antagonists are potential antidepressants: evidence based on pharmacology and A(2A) receptor knockout mice, BR J PHARM, 134(1), 2001, pp. 68-77
Authors:
Corradini, L
Briscini, L
Ongini, E
Bertorelli, R
Citation: L. Corradini et al., The putative OP4 antagonist, [Nphe(1)]nociceptin(1-13)NH2, prevents the effects of nociceptin in neuropathic rats, BRAIN RES, 905(1-2), 2001, pp. 127-133
Authors:
Parker, EM
Monopoli, A
Ongini, E
Lozza, G
Babij, CM
Citation: Em. Parker et al., Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12cells by inhibiting cell cycle progression, NEUROPHARM, 39(10), 2000, pp. 1913-1919
Authors:
Grilli, M
Lozza, G
Brusa, R
Casarini, M
Uberti, D
Rozmahel, R
Westaway, D
St George-Hyslop, P
Memo, M
Ongini, E
Citation: M. Grilli et al., Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically, P NAS US, 97(23), 2000, pp. 12822-12827
Authors:
Varani, K
Portaluppi, F
Gessi, S
Merighi, S
Ongini, E
Belardinelli, L
Borea, PA
Citation: K. Varani et al., Dose and time effects of caffeine intake on human platelet adenosine A(2A)receptors - Functional and biochemical aspects, CIRCULATION, 102(3), 2000, pp. 285-289
Authors:
Baraldi, PG
Borea, PA
Bergonzoni, M
Cacciari, B
Ongini, E
Recanatini, M
Spalluto, G
Citation: Pg. Baraldi et al., Comparative molecular field analysis (CoMFA) of a series of selective adenosine receptor A(2A) antagonists, DRUG DEV R, 46(2), 1999, pp. 126-133
Authors:
Ongini, E
Dionisotti, S
Gessi, S
Irenius, E
Fredholm, BB
Citation: E. Ongini et al., Comparison of CGS15943, ZM241385 and SCH58261 as antagonists at human adenosine receptors, N-S ARCH PH, 359(1), 1999, pp. 7-10
Authors:
Bertorelli, R
Corradini, L
Rafiq, K
Tupper, J
Calo, G
Ongini, E
Citation: R. Bertorelli et al., Nociceptin and the ORL-1 ligand [Phe(1)psi (CH2-NH)Gly(2)]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain, BR J PHARM, 128(6), 1999, pp. 1252-1258
Authors:
Monopoli, A
Lozza, G
Forlani, A
Mattavelli, A
Ongini, E
Citation: A. Monopoli et al., Blockade of adenosine A(2A) receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats, NEUROREPORT, 9(17), 1998, pp. 3955-3959
Citation: E. Ongini et P. Schubert, Neuroprotection induced by stimulating A(1) or blocking A(2A) adenosine receptors: An apparent paradox, DRUG DEV R, 45(3-4), 1998, pp. 387-393